1. Home
  2. KYTX vs LTRX Comparison

KYTX vs LTRX Comparison

Compare KYTX & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • LTRX
  • Stock Information
  • Founded
  • KYTX 2018
  • LTRX 1989
  • Country
  • KYTX United States
  • LTRX United States
  • Employees
  • KYTX N/A
  • LTRX N/A
  • Industry
  • KYTX
  • LTRX Computer Communications Equipment
  • Sector
  • KYTX
  • LTRX Telecommunications
  • Exchange
  • KYTX NYSE
  • LTRX Nasdaq
  • Market Cap
  • KYTX 92.1M
  • LTRX 85.6M
  • IPO Year
  • KYTX 2024
  • LTRX 2000
  • Fundamental
  • Price
  • KYTX $3.07
  • LTRX $2.52
  • Analyst Decision
  • KYTX Strong Buy
  • LTRX Strong Buy
  • Analyst Count
  • KYTX 5
  • LTRX 5
  • Target Price
  • KYTX $19.00
  • LTRX $5.10
  • AVG Volume (30 Days)
  • KYTX 415.4K
  • LTRX 266.0K
  • Earning Date
  • KYTX 08-11-2025
  • LTRX 05-08-2025
  • Dividend Yield
  • KYTX N/A
  • LTRX N/A
  • EPS Growth
  • KYTX N/A
  • LTRX N/A
  • EPS
  • KYTX N/A
  • LTRX N/A
  • Revenue
  • KYTX N/A
  • LTRX $143,159,000.00
  • Revenue This Year
  • KYTX N/A
  • LTRX N/A
  • Revenue Next Year
  • KYTX N/A
  • LTRX $3.61
  • P/E Ratio
  • KYTX N/A
  • LTRX N/A
  • Revenue Growth
  • KYTX N/A
  • LTRX N/A
  • 52 Week Low
  • KYTX $1.78
  • LTRX $1.91
  • 52 Week High
  • KYTX $11.40
  • LTRX $4.55
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 55.92
  • LTRX 60.21
  • Support Level
  • KYTX $2.86
  • LTRX $2.28
  • Resistance Level
  • KYTX $2.82
  • LTRX $2.62
  • Average True Range (ATR)
  • KYTX 0.31
  • LTRX 0.13
  • MACD
  • KYTX -0.03
  • LTRX 0.02
  • Stochastic Oscillator
  • KYTX 40.94
  • LTRX 80.00

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

Share on Social Networks: